Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

被引:1003
作者
Albert, ML
Pearce, SFA
Francisco, LM
Sauter, B
Roy, P
Silverstein, RL
Bhardwaj, N
机构
[1] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA
[2] Cornell Univ, Div Hematol Oncol, Coll Med, New York, NY 10021 USA
关键词
dendritic cells; phagocytosis; CD36; integrins; cross-presentation;
D O I
10.1084/jem.188.7.1359
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells, but not macrophages, efficiently phagocytose apoptotic cells and cross-present viral, tumor, and self-antigens to CD8(+) T cells. This in vitro pathway corresponds to the in vivo phenomena of cross-priming and cross-tolerance. Here, we demonstrate that phagocytosis of apoptotic cells is restricted to the immature stage of dendritic cell (DC) development, and that this process is accompanied by the expression of a unique profile of receptors, in particular the alpha(v)beta(5) integrin and CD36. Upon maturation, these receptors and, in turn, the phagocytic capacity of DCs, are downmodulated. Macrophages engulf apoptotic cells more efficiently than DCs, and although they express many receptors that mediate this uptake, they lack the alpha(v)beta(5) integrin. Furthermore, in contrast to DCs, macrophages fail to cross-present antigenic material contained within the engulfed apoptotic cells. Thus, DCs use unique pathways for the phagocytosis, processing, and presentation of antigen derived from apoptotic cells on class I major histocompatibility complex. We suggest that the alpha(v)beta(5) integrin plays a critical role in the trafficking of exogenous antigen by immature DCs in this cross-priming pathway.
引用
收藏
页码:1359 / 1368
页数:10
相关论文
共 51 条
[31]   Developmental regulation of MHC class II transport in mouse dendritic cells [J].
Pierre, P ;
Turley, SJ ;
Gatti, E ;
Hull, M ;
Meltzer, J ;
Mirza, A ;
Inaba, K ;
Steinman, RM ;
Mellman, I .
NATURE, 1997, 388 (6644) :787-792
[32]   CD36 GENE-TRANSFER CONFERS CAPACITY FOR PHAGOCYTOSIS OF CELLS UNDERGOING APOPTOSIS [J].
REN, Y ;
SILVERSTEIN, RL ;
ALLEN, J ;
SAVILL, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1857-1862
[33]   Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: Synergistic activation of interleukin 12 production [J].
Rieser, C ;
Bock, G ;
Klocker, H ;
Bartsch, G ;
Thurnher, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (09) :1603-1608
[34]   Generation of mature dendritic cells from human blood - An improved method with special regard to clinical applicability [J].
Romani, N ;
Reider, D ;
Heuer, M ;
Ebner, S ;
Kampgen, E ;
Eibl, B ;
Niederwieser, D ;
Schuler, G .
JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 196 (02) :137-151
[35]   The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha v beta 3 integrin and requires intracellular and extracellular calcium [J].
Rubartelli, A ;
Poggi, A ;
Zocchi, MR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (08) :1893-1900
[36]  
Ryeom SW, 1996, J CELL SCI, V109, P387
[37]   Ceramide inhibits antigen uptake and presentation by dendritic cells [J].
Sallusto, F ;
Nicolo, C ;
DeMaria, R ;
Corinti, S ;
Testi, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (06) :2411-2416
[38]   DENDRITIC CELLS USE MACROPINOCYTOSIS AND THE MANNOSE RECEPTOR TO CONCENTRATE MACROMOLECULES IN THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II COMPARTMENT - DOWN-REGULATION BY CYTOKINES AND BACTERIAL PRODUCTS [J].
SALLUSTO, F ;
CELLA, M ;
DANIELI, C ;
LANZAVECCHIA, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (02) :389-400
[39]   Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/Macrophage Colony-stimulating Factor Plus Interleukin 4 and Downregulated by Tumor Necrosis Factor α [J].
Sallusto, Federica ;
Lanzavecchia, Antonio .
JOURNAL OF IMMUNOLOGY, 2018, 200 (03) :887-896
[40]   THROMBOSPONDIN COOPERATES WITH CD36 AND THE VITRONECTIN RECEPTOR IN MACROPHAGE RECOGNITION OF NEUTROPHILS UNDERGOING APOPTOSIS [J].
SAVILL, J ;
HOGG, N ;
REN, Y ;
HASLETT, C .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) :1513-1522